<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934 and Rule 13a-17 or 5d-17 thereunder
AGOURON PHARMACEUTICALS, INC.
- -------------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
10350 N. Torrey Pines Road, Suite 100, La Jolla, CA 92037
- -------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (619) 622-3000
--------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of securities Common Stock without par value
-------------------------------------------------------
2. Number of shares outstanding before the change 7,359,282
----------------------------
3. Number of shares outstanding after the change 10,359,282
-----------------------------
4. Effective date of change September 20, 1995
--------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
Distribution
---------------------------------------------------------------------------
Give brief description of transaction Public offering of 3,000,000 shares
-------------------------------------
of no par common stock under Form S-3 Registration Statement
---------------------------------------------------------------------------
(No. 33-61573). PaineWebber Incorporated and Robertson, Stephens & Company,
---------------------------------------------------------------------------
L.P. acted as representatives for the Underwriters.
---------------------------------------------------------------------------
---------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
------------------------------------------------------
2. Name after change
---------------------------------------------------------
3. Effective date of charter amendment changing name
-------------------------
4. Date of shareholder approval of change, if required
-----------------------
Date: September 28, 1995 Steven S. Cowell
---------------------- ------------------------
Steven S. Cowell
Vice President, Finance and Chief
Financial Officer
